Li, Hui
Zhang, Mingming
Wei, Yanli
Haider, Farhan
Lin, Yitong
Guan, Wen
Liu, Yanbin
Zhang, Shaoyang
Yuan, Ronghua
Yang, Xia
Yang, Shulan
Wang, Haihe
Funding for this research was provided by:
National Natural Science Foundation of China (81672704, 81171947)
International Collaboration Project of Natural Science Foundation of Guangdong Province (2014A050503030)
Guandong Science and Technology Project (2015B090903063)
Article History
Received: 25 November 2019
Accepted: 22 April 2020
First Online: 7 May 2020
Ethics approval and consent to participate
: The research was approved by the Ethics Committee of Sun Yat-Sen University.
: All subjects have written informed consent.
: Drs. Haihe Wang and Shulan Yang, researchers on the study team, are co-inventors on Patent 201710512823.6 (Sun Yat-sen University) which deals with the application of SH3BGRL as a diagnostic and therapy target. No other authors have competing interests.